SCHEMBL17023148

SCHEMBL17023148

CNCc1c[nH]c(NC(=O)Oc2ccc(-c3c(F)c(OC)cc(OC)c3F)c3nccnc23)n1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023165 0.89 FGFR3 (0.55) FGFR3
SCHEMBL17023053 0.88 FGFR3 (0.46) FGFR3
SCHEMBL17023114 0.88 FGFR3 (0.57) FGFR3
SCHEMBL1126376 0.88 FGFR3 (0.61) FGFR3
SCHEMBL17023140 0.87 FGFR3 (0.48) FGFR3
SCHEMBL17023182 0.87 FGFR3 (0.50) FGFR3
SCHEMBL17023076 0.86 FGFR3 (0.56) FGFR3
SCHEMBL17023094 0.85 FGFR3 (0.59) FGFR3
SCHEMBL17023155 0.84 FGFR3 (0.47) FGFR3
SCHEMBL17023079 0.83 FGFR3 (0.58) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed